Dr. Alex Colville joins forces with Laura Deming to lead investments in longevity science moonshots, after deploying $100M fund last year while at Stanford
age1, a venture capital firm catalyzing ...
The times are changing in biopharma.
With the top drugmakers no longer committing most of their resources to the pandemic, biopharma is returning to its roots. But it’s clear the ...
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
A little over 15 years ago, scientists at Kyoto University in Japan made a remarkable discovery. When they ...
